Zenotech Laboratories Limited (ZENOTECH.BO)

INR 70.8

(-0.97%)

Market Cap (In INR)

4.32 Billion

Revenue (In INR)

368.08 Million

Net Income (In INR)

82.98 Million

Avg. Volume

28.36 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
12.0-73.0
PE
-
EPS
-
Beta Value
1.1357958
ISIN
INE486F01012
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Devendra C. S. Kenkre
Employee Count
-
Website
http://www.zenotechlab.com
Ipo Date
2004-03-01
Details
Zenotech Laboratories Ltd. engages in the manufacture and marketing of pharmaceuticals products. The firm involves in the production of granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). Its injectable product portfolio serves niche therapy areas like oncology and anesthesiology. The company was founded on June 15, 1989 and is headquartered in Hyderabad, India.